Insider Transactions for Travere Therapeutics, Inc. (RTRX)

Symbol CompanyOwnerRelationshipDateTransactionCost# SharesValue ($)Total SharesFiling
TVTXTravere Therapeutics, Inc.Dube Eric MCHIEF EXECUTIVE OFFICERFeb 01, 2024Sale$8.7019,122166,435360,616Feb 02, 2024, 04:06 PM
TVTXTravere Therapeutics, Inc.ROTE WILLIAM E.SENIOR VICE PRESIDENT, R&DFeb 01, 2024Sale$8.714,76441,49583,310Feb 02, 2024, 04:05 PM
TVTXTravere Therapeutics, Inc.Calvin SandraSVP, CHIEF ACCOUNTING OFFICERFeb 01, 2024Sale$8.532,82024,05852,017Feb 02, 2024, 04:05 PM
TVTXTravere Therapeutics, Inc.REED ELIZABETH ESVP, GC & CORPORATE SECRETARYJan 23, 2024Sale$8.962,06218,47656,034Jan 25, 2024, 04:10 PM
TVTXTravere Therapeutics, Inc.Dube Eric MCHIEF EXECUTIVE OFFICERJan 23, 2024Sale$8.967,87370,542234,722Jan 25, 2024, 04:10 PM
TVTXTravere Therapeutics, Inc.Cline Christopher R.CHIEF FINANCIAL OFFICERJan 23, 2024Sale$9.078537,73549,721Jan 25, 2024, 04:10 PM
TVTXTravere Therapeutics, Inc.ROTE WILLIAM E.SENIOR VICE PRESIDENT, R&DJan 23, 2024Sale$8.962,06218,47660,484Jan 25, 2024, 04:10 PM
TVTXTravere Therapeutics, Inc.Calvin SandraSVP, CHIEF ACCOUNTING OFFICERJan 23, 2024Sale$9.079108,25241,337Jan 25, 2024, 04:10 PM
TVTXTravere Therapeutics, Inc.Heerma PeterCHIEF COMMERCIAL OFFICERJan 23, 2024Sale$9.071,55914,13878,698Jan 25, 2024, 04:10 PM
TVTXTravere Therapeutics, Inc.Inrig JulaChief Medical OfficerJan 04, 2024Sale$9.174404,03535,248Jan 05, 2024, 04:11 PM
TVTXTravere Therapeutics, Inc.Inrig JulaChief Medical OfficerJan 03, 2024Sale$9.482,06919,61335,688Jan 05, 2024, 04:11 PM
TVTXTravere Therapeutics, Inc.Heerma PeterChief Commercial OfficerOct 03, 2023Sale$8.253,09125,50480,257Oct 04, 2023, 04:05 PM
TVTXTravere Therapeutics, Inc.Cline Christopher R.Chief Financial OfficerSep 05, 2023Sale$14.714576,72350,574Sep 05, 2023, 08:15 PM
TVTXTravere Therapeutics, Inc.ROTE WILLIAM E.Senior Vice President, R&DSep 05, 2023Sale$14.711,81526,69961,173Sep 05, 2023, 08:13 PM
TVTXTravere Therapeutics, Inc.REED ELIZABETH ESVP, GC & Corporate SecretarySep 05, 2023Sale$14.711,81526,69958,096Sep 05, 2023, 08:12 PM
TVTXTravere Therapeutics, Inc.Dube Eric MChief Executive OfficerSep 05, 2023Sale$14.714,45565,533242,595Sep 05, 2023, 08:10 PM
TVTXTravere Therapeutics, Inc.Cline Christopher R.Chief Financial OfficerMay 10, 2023Sale$16.594557,54851,031May 12, 2023, 04:14 PM
TVTXTravere Therapeutics, Inc.REED ELIZABETH ESVP, GC & Corporate SecretaryMay 10, 2023Sale$16.5982513,68756,611May 12, 2023, 04:11 PM
TVTXTravere Therapeutics, Inc.ROTE WILLIAM E.Senior Vice President, R&DMay 10, 2023Sale$16.5982513,68759,211May 12, 2023, 04:09 PM
TVTXTravere Therapeutics, Inc.Calvin SandraSVP, Chief Accounting OfficerMay 10, 2023Sale$16.594367,23342,369May 12, 2023, 04:06 PM
TVTXTravere Therapeutics, Inc.Calvin SandraSVP, Chief Accounting OfficerMay 11, 2023Sale$16.121221,96742,247May 12, 2023, 04:06 PM
TVTXTravere Therapeutics, Inc.Cline Christopher R.Chief Financial OfficerApr 11, 2023Sale$21.49471,01051,486Apr 13, 2023, 04:07 PM
TVTXTravere Therapeutics, Inc.REED ELIZABETH ESVP, GC & Corporate SecretaryFeb 01, 2023Sale$22.252,59057,62857,436Feb 02, 2023, 07:11 PM
TVTXTravere Therapeutics, Inc.ROTE WILLIAM E.Senior Vice President, R&DFeb 01, 2023Sale$22.252,59057,62860,036Feb 02, 2023, 07:08 PM
TVTXTravere Therapeutics, Inc.Heerma PeterChief Commercial OfficerFeb 01, 2023Sale$21.751,77938,69782,069Feb 02, 2023, 07:04 PM
TVTXTravere Therapeutics, Inc.Cline Christopher R.Chief Financial OfficerFeb 01, 2023Sale$21.751,58834,54251,533Feb 02, 2023, 07:02 PM
TVTXTravere Therapeutics, Inc.Dube Eric MChief Executive OfficerFeb 01, 2023Sale$22.258,196182,361237,150Feb 02, 2023, 06:58 PM
TVTXTravere Therapeutics, Inc.Calvin SandraSVP, Chief Accounting OfficerFeb 01, 2023Sale$21.751,67136,34843,165Feb 02, 2023, 06:53 PM
TVTXTravere Therapeutics, Inc.Calvin SandraSVP, Chief Accounting OfficerFeb 02, 2023Sale$22.423608,07142,805Feb 02, 2023, 06:53 PM
TVTXTravere Therapeutics, Inc.Calvin SandraSVP, Chief Accounting OfficerJan 24, 2023Sale$21.9090519,82335,028Jan 26, 2023, 04:05 PM
TVTXTravere Therapeutics, Inc.Calvin SandraSVP, Chief Accounting OfficerJan 25, 2023Sale$21.631924,15334,836Jan 26, 2023, 04:05 PM
TVTXTravere Therapeutics, Inc.ROTE WILLIAM E.Senior Vice President, R&DJan 24, 2023Sale$21.502,06244,33342,376Jan 26, 2023, 04:05 PM
TVTXTravere Therapeutics, Inc.REED ELIZABETH ESVP, GC & Corporate SecretaryJan 24, 2023Sale$21.502,06244,33339,776Jan 26, 2023, 04:05 PM
TVTXTravere Therapeutics, Inc.Dube Eric MChief Executive OfficerJan 24, 2023Sale$21.506,442138,503147,846Jan 26, 2023, 04:05 PM
TVTXTravere Therapeutics, Inc.Cline Christopher R.Chief Financial OfficerJan 24, 2023Sale$21.9085218,66332,871Jan 26, 2023, 04:05 PM
TVTXTravere Therapeutics, Inc.Heerma PeterChief Commercial OfficerJan 24, 2023Sale$21.901,55033,95263,598Jan 26, 2023, 04:05 PM
TVTXTravere Therapeutics, Inc.Dube Eric MChief Executive OfficerJan 05, 2023Sale$20.755,625116,719154,288Jan 06, 2023, 04:05 PM
TVTXTravere Therapeutics, Inc.Inrig JulaChief Medical OfficerJan 05, 2023Sale$20.754429,17217,507Jan 06, 2023, 04:05 PM
TVTXTravere Therapeutics, Inc.Inrig JulaChief Medical OfficerJan 04, 2023Sale$20.752,05142,55817,949Jan 06, 2023, 04:05 PM
TVTXTravere Therapeutics, Inc.Heerma PeterChief Commercial OfficerOct 04, 2022Sale$25.683,04278,11965,148Oct 06, 2022, 08:10 PM
TVTXTravere Therapeutics, Inc.Calvin SandraSVP, Chief Accounting OfficerSep 13, 2022Sale$28.003499,77235,933Sep 15, 2022, 04:05 PM
TVTXTravere Therapeutics, Inc.ROTE WILLIAM E.Senior Vice President, R&DMay 11, 2022Sale$21.711,56333,94044,485May 12, 2022, 08:49 PM
TVTXTravere Therapeutics, Inc.REED ELIZABETH ESVP, GC & Corporate SecretaryMay 10, 2022Sale$21.5190019,35942,888May 12, 2022, 08:47 PM
TVTXTravere Therapeutics, Inc.REED ELIZABETH ESVP, GC & Corporate SecretaryMay 12, 2022Sale$21.511,05022,58441,838May 12, 2022, 08:47 PM
TVTXTravere Therapeutics, Inc.Clague LauraChief Financial OfficerMay 10, 2022Sale$21.5182517,74637,030May 12, 2022, 08:45 PM
TVTXTravere Therapeutics, Inc.Clague LauraChief Financial OfficerMay 11, 2022Sale$21.511,37529,57635,655May 12, 2022, 08:45 PM
TVTXTravere Therapeutics, Inc.Calvin SandraSVP, Chief Accounting OfficerMay 11, 2022Sale$21.924459,75635,733May 12, 2022, 08:44 PM
TVTXTravere Therapeutics, Inc.Calvin SandraSVP, Chief Accounting OfficerMay 10, 2022Sale$21.514369,37836,178May 12, 2022, 08:44 PM
TVTXTravere Therapeutics, Inc.ASELAGE STEVEDirectorMay 11, 2022Sale$21.922,57556,457146,919May 12, 2022, 08:35 PM
TVTXTravere Therapeutics, Inc.Dube Eric MChief Executive OfficerFeb 10, 2022Sale$27.844,832134,523159,913Feb 11, 2022, 04:05 PM
TVTXTravere Therapeutics, Inc.Calvin SandraVP, Corp Controller and CAOJan 31, 2022Sale$26.5179821,15236,614Feb 02, 2022, 04:22 PM
TVTXTravere Therapeutics, Inc.REED ELIZABETH ESVP, GC & Corporate SecretaryJan 31, 2022Sale$27.401,35036,99043,788Feb 02, 2022, 04:20 PM
TVTXTravere Therapeutics, Inc.ROTE WILLIAM E.Senior Vice President, R&DJan 31, 2022Sale$27.401,12530,82545,235Feb 02, 2022, 04:19 PM
TVTXTravere Therapeutics, Inc.Heerma PeterChief Commercial OfficerJan 31, 2022Sale$27.401,12530,82567,297Feb 02, 2022, 04:18 PM
TVTXTravere Therapeutics, Inc.Clague LauraChief Financial OfficerJan 31, 2022Sale$27.401,23833,92137,855Feb 02, 2022, 04:17 PM
TVTXTravere Therapeutics, Inc.Dube Eric MChief Executive OfficerJan 31, 2022Sale$27.404,813131,876164,745Feb 02, 2022, 04:16 PM
TVTXTravere Therapeutics, Inc.Calvin SandraVP, Corp Controller and CAOJan 24, 2022Sale$24.5893422,95528,662Jan 26, 2022, 04:38 PM
TVTXTravere Therapeutics, Inc.ROTE WILLIAM E.Senior Vice President, R&DJan 24, 2022Sale$24.981,87546,83736,520Jan 26, 2022, 04:37 PM
TVTXTravere Therapeutics, Inc.Heerma PeterChief Commercial OfficerJan 24, 2022Sale$24.981,87546,83758,582Jan 26, 2022, 04:36 PM
TVTXTravere Therapeutics, Inc.REED ELIZABETH ESVP, GC & Corporate SecretaryJan 24, 2022Sale$24.982,25056,20535,298Jan 26, 2022, 04:35 PM
TVTXTravere Therapeutics, Inc.Clague LauraChief Financial OfficerJan 24, 2022Sale$24.982,06351,53429,253Jan 26, 2022, 04:34 PM
TVTXTravere Therapeutics, Inc.Dube Eric MChief Executive OfficerJan 24, 2022Sale$24.987,873196,668131,710Jan 26, 2022, 04:33 PM
TVTXTravere Therapeutics, Inc.REED ELIZABETH ESVP, GC & Corporate SecretaryJan 11, 2022Sale$27.405,000137,00037,548Jan 12, 2022, 04:07 PM
TVTXTravere Therapeutics, Inc.ROTE WILLIAM E.Senior Vice President, R&DJan 11, 2022Sale$27.402,50068,50038,395Jan 12, 2022, 04:06 PM
TVTXTravere Therapeutics, Inc.Clague LauraChief Financial OfficerJan 11, 2022Sale$27.407,500205,50031,316Jan 12, 2022, 04:05 PM
TVTXTravere Therapeutics, Inc.Dube Eric MChief Executive OfficerJan 04, 2022Sale$30.434,832147,038152,083Jan 06, 2022, 04:03 PM
TVTXTravere Therapeutics, Inc.Dube Eric MChief Executive OfficerJan 05, 2022Sale$29.9512,500374,369141,722Jan 06, 2022, 04:03 PM
TVTXTravere Therapeutics, Inc.ASELAGE STEVEDirectorNov 16, 2021Sale$29.3931,800934,602149,494Nov 18, 2021, 04:08 PM
TVTXTravere Therapeutics, Inc.ASELAGE STEVEDirectorNov 05, 2021Option Exercise$21.2320,000424,600171,794Nov 09, 2021, 04:05 PM
TVTXTravere Therapeutics, Inc.ASELAGE STEVEDirectorNov 01, 2021Sale$29.485,000147,40023,000Nov 03, 2021, 04:05 PM
TVTXTravere Therapeutics, Inc.ASELAGE STEVEDirectorNov 02, 2021Sale$30.003,500105,00019,500Nov 03, 2021, 04:05 PM
TVTXTravere Therapeutics, Inc.ASELAGE STEVEDirectorOct 07, 2021Sale$21.24120,0002,548,560249,794Oct 08, 2021, 04:18 PM
TVTXTravere Therapeutics, Inc.Heerma PeterChief Commercial OfficerOct 04, 2021Sale$24.773,05875,74660,457Oct 05, 2021, 04:06 PM
TVTXTravere Therapeutics, Inc.Heerma PeterChief Commercial OfficerAug 17, 2021Sale$17.121,40724,08663,515Aug 17, 2021, 07:41 PM
TVTXTravere Therapeutics, Inc.Dube Eric MChief Executive OfficerAug 17, 2021Sale$17.127,836134,142156,915Aug 17, 2021, 07:40 PM
TVTXTravere Therapeutics, Inc.Rosenberg Noah L.Chief Medical OfficerAug 17, 2021Sale$17.121,40724,08547,614Aug 17, 2021, 07:39 PM
TVTXTravere Therapeutics, Inc.ROTE WILLIAM E.Senior Vice President, R&DAug 17, 2021Sale$17.121,40724,08535,731Aug 17, 2021, 07:38 PM
TVTXTravere Therapeutics, Inc.REED ELIZABETH ESVP, GC & Corporate SecretaryAug 17, 2021Sale$17.121,40724,08637,548Aug 17, 2021, 07:35 PM
TVTXTravere Therapeutics, Inc.Clague LauraChief Financial OfficerAug 17, 2021Sale$17.121,40724,08531,316Aug 17, 2021, 07:34 PM
TVTXTravere Therapeutics, Inc.Rosenberg Noah L.Chief Medical OfficerJul 28, 2021Sale$13.811,25017,26344,521Jul 29, 2021, 04:09 PM
TVTXTravere Therapeutics, Inc.ASELAGE STEVEDirectorApr 16, 2021Option Exercise$21.2320,000424,600198,940Apr 20, 2021, 04:05 PM
TVTXTravere Therapeutics, Inc.ASELAGE STEVEDirectorMar 17, 2021Sale$23.4027,727648,756206,667Mar 19, 2021, 04:05 PM
TVTXTravere Therapeutics, Inc.ROTE WILLIAM E.Senior Vice President, R&DFeb 17, 2021Sale$27.351,25034,18836,082Feb 18, 2021, 06:26 PM
TVTXTravere Therapeutics, Inc.ROTE WILLIAM E.Senior Vice President, R&DFeb 18, 2021Sale$28.671,25035,83834,832Feb 18, 2021, 06:26 PM
TVTXTravere Therapeutics, Inc.Rosenberg Noah L.Chief Medical OfficerFeb 05, 2021Sale$31.411,12535,33647,469Feb 09, 2021, 04:32 PM
TVTXTravere Therapeutics, Inc.Rosenberg Noah L.Chief Medical OfficerFeb 08, 2021Sale$31.581,12535,52746,344Feb 09, 2021, 04:32 PM
TVTXTravere Therapeutics, Inc.Heerma PeterChief Commercial OfficerFeb 05, 2021Sale$31.411,12535,33660,469Feb 09, 2021, 04:31 PM
TVTXTravere Therapeutics, Inc.Heerma PeterChief Commercial OfficerFeb 08, 2021Sale$31.581,12535,52759,344Feb 09, 2021, 04:31 PM
TVTXTravere Therapeutics, Inc.ROTE WILLIAM E.Senior Vice President, R&DFeb 08, 2021Sale$31.582,25071,05537,332Feb 09, 2021, 04:30 PM
TVTXTravere Therapeutics, Inc.ROTE WILLIAM E.Senior Vice President, R&DFeb 05, 2021Sale$31.412,25070,67239,582Feb 09, 2021, 04:30 PM
TVTXTravere Therapeutics, Inc.REED ELIZABETH ESVP, GC & Corporate SecretaryFeb 05, 2021Sale$31.412,25070,67239,955Feb 09, 2021, 04:30 PM
TVTXTravere Therapeutics, Inc.REED ELIZABETH ESVP, GC & Corporate SecretaryFeb 08, 2021Sale$31.582,25071,05537,705Feb 09, 2021, 04:30 PM
TVTXTravere Therapeutics, Inc.Clague LauraChief Financial OfficerFeb 05, 2021Sale$31.412,25070,67234,473Feb 09, 2021, 04:29 PM
TVTXTravere Therapeutics, Inc.Clague LauraChief Financial OfficerFeb 08, 2021Sale$31.582,25071,05532,223Feb 09, 2021, 04:29 PM
TVTXTravere Therapeutics, Inc.Dube Eric MChief Executive OfficerFeb 08, 2021Sale$31.584,813151,995156,813Feb 09, 2021, 04:28 PM
TVTXTravere Therapeutics, Inc.Dube Eric MChief Executive OfficerFeb 05, 2021Sale$31.414,813151,176161,626Feb 09, 2021, 04:28 PM
TVTXTravere Therapeutics, Inc.Heerma PeterChief Commercial OfficerFeb 02, 2021Sale$30.7556317,31257,657Feb 03, 2021, 09:33 PM
TVTXTravere Therapeutics, Inc.Heerma PeterChief Commercial OfficerFeb 03, 2021Sale$28.9156316,27657,094Feb 03, 2021, 09:33 PM
TVTXTravere Therapeutics, Inc.Rosenberg Noah L.Chief Medical OfficerFeb 03, 2021Sale$28.911,81352,41444,657Feb 03, 2021, 09:33 PM
TVTXTravere Therapeutics, Inc.ROTE WILLIAM E.Senior Vice President, R&DFeb 03, 2021Sale$28.913,625104,79938,457Feb 03, 2021, 09:32 PM